Intended for healthcare professionals


Screening for ovarian cancer is ruled out after trial found it did not reduce deaths

BMJ 2021; 373 doi: (Published 12 May 2021) Cite this as: BMJ 2021;373:n1223
  1. Nikki Nabavi
  1. The BMJ

A large trial of annual screening tests for ovarian cancer showed they did not reduce deaths despite picking up cancers earlier,1 ruling out the possibility of a national population screening programme.

The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), led by UCL researchers, looked at data from more than 200 000 women who were aged 50-74, and followed them up for an average of 16 years. The women were randomly allocated to one of three groups: no screening, …

View Full Text

Log in

Log in through your institution


* For online subscription